Literature DB >> 8546121

Bias in case-control studies of screening effectiveness.

R S Hosek1, W D Flanders, A J Sasco.   

Abstract

Screening programs, such as annual mammography, are undertaken to reduce mortality and/or morbidity from chronic diseases such as cancer. Matched case-control studies have been used to assess the effectiveness of screening programs because of their relative simplicity and low cost. In such studies, the exposure history for controls consists of the number of screening examinations received prior to the date of diagnosis of the matched case. The authors know of no methodological evaluations that demonstrate the validity of such case-control studies. To examine the possible existence of bias due to design rules, the authors developed a simple deterministic model, which is used to calculate expected screening and disease patterns in a cohort. Cases and matched controls are selected from the cohort, and their screening histories are used to calculate an odds ratio, as is commonly done in practice. Results utilizing this simple model suggest that systematic inclusion of the examination from which diagnosis is made, which is the approach typically used in practice, leads to a positive bias (odds ratio > 1) in the absence of any real effect. Systematic exclusion of this examination appears to lead to a negative bias (odds ratio < 1). Although this simple approach has several limitations, the results suggest that a commonly used method of conducting case-control studies may yield biased odds ratios. Possible methods to reduce this bias may exist, such as defining exposure intervals differently.

Entities:  

Mesh:

Year:  1996        PMID: 8546121     DOI: 10.1093/oxfordjournals.aje.a008729

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  3 in total

1.  Population-based case-control study of PSA and DRE screening on prostate cancer mortality.

Authors:  Eric J Bergstralh; Rosebud O Roberts; Sara A Farmer; Jeffrey M Slezak; Michael M Lieber; Steven J Jacobsen
Journal:  Urology       Date:  2007-11       Impact factor: 2.649

2.  An evaluation of screening for lung cancer in Niigata Prefecture, Japan: a population-based case-control study.

Authors:  H Tsukada; Y Kurita; A Yokoyama; S Wakai; T Nakayama; M Sagawa; H Misawa
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640

3.  Seventeen-year evaluation of breast cancer screening: the DOM project, The Netherlands. Diagnostisch Onderzoek (investigation) Mammacarcinoom.

Authors:  G A Miltenburg; P H Peeters; J Fracheboud; H J Collette
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.